Abstract:Objective Expression of the human sodium/iodide symporter(hNIS)in the thyroid gland provides for effective imaging and treatment of thyroid cancer using radiolabeled iodide.Transfer of hNIS gene into other tumors would expand the utility of this treatment to tumors of nonthyroid origin.The human telomerase reverse transcriptase(hTERT)is overexpressed in tumor cells.but is not expressed in normal cells.The aim of this study was to construct a recombinant adenovirus containing the hNIS under the control of hTERT core promoter to express specially on tumor cells.and to investigate the feasibility of radioiodine therapy mediated by hNIS gene controlled with hTERT promoter.Methods The recombinant adenovirus Ad-hTERT-hNIS was constructed by AdEasy system.In addition.a positive control of adenovirus Adcytomegalovirus(CMV)-hNIS containing the CMV promoter followed with hNIS gene and a negative control of adenovirus Ad-CMV not containing hNIS gene were created by AdEasy system.The cell-specific transcriptional activity of hTERT was examined by reverse transcriptase-polymerase chain reaction(RT-PCR)in transiently transfected A549 cell lines.Iodide uptake assays were used to confirm hNIS expression and funetion.Toxic effects of131 I on tumor cells were studied by in vitro clonogenic assay.Results Recombinant Ad-hTERT-hNIS was correctly constructed and confirmed by restriction enzyme analysis and PCR.RT-PCRshowed that hNIS cDNA could be amplified by the transfeeted cells.A 23-fold and 31-fold increase in iodide uptake was observed in Ad-hTERT-hNIS and Ad-CMV-hNIS infected A549 cells.respectively.No significant iodide uptake increase was detected in cells infected with the negative control virus.The iodide uptake in transfected cells was inhibited by sodium perchlorate.In vitro elonogenic assay revealed that approximately 70%[(31.2 ±1.45)%A549 cells alive ] of Ad-hTERT-hNIS and 80%[(23.6 ±4.08)%A549 cells alive]of Ad-CMV-hNIS transfected A549 cells were killed by exposure to131 I.respectively.while only about 10% of NIS-negative control cells were killed [(89.0 ±2.99)%A549 cells alive for Ad-CMV group and(91.2 ± 4.63)%A549 cells alive for no-infected group ].Conclusion Radioiodine therapy following tumor cells transfected with recombinant adenovirus Ad-hTERT-hNIS may likely be a successful entity benefited by this novel gene targeting therapy strategy.

The Study of Iodide Uptake Change by Transfection of A Recombinant Eukaryotic Expression Plasmid Pcdna3.1/Htshr Cdna in Ftc-133 Cell Lines

The Effects of Human TSH Receptor Gene Transfection on Iodide Uptake and Thyroid-Specific Gene Expression in Poorly Differentiated Thyroid Carcinoma Cell Line

Re-induction of cell differentiation and 131I uptake in dedifferentiated FTC-133 cell line by TSHR gene transfection

Efficacy of lentiviral-mediated transfection of hTSHR in poorly differentiated thyroid carcinoma cell line.

Experimental Study of Retinoic Acid Increases Iodide Uptake in Human Thyroid Cancer Cell Lines

Decreasc of Iodine Uptake Capability and Pertinent Genes Expressions in Differentiated Thyroid Carcinoma(DTC)Cell Line Cultures After 131ⅠIrradiation

Combination of all-trans retinoic acid with tributyrin induced human folliculat thyroid carcinoma

Experimental study of tumor targeted therapy with sodium iodide symporter gene regulated by human telomerase reverse transcriptase promoter

Radioiodide uptake and therapy of lung cancer cells mediated by human sodium iodide symporter gene

Functional Study of Human TSH Receptor Transfected into Chinese Hamster Ovary Cells

Efficient Multicistronic Co-Expression of Hnis and Htpo in Prostate Cancer Cells for Nonthyroidal Tumor Radioiodine Therapy.

Dedifferentiation of Differentiated Thyroid Carcinoma Cell Line FTC-133 is Enhanced by 131I Pretreatment.

Sodium-iodine symporter gene expression controlled by the EGR-1 promoter: biodistribution, imaging and in vitro radionuclide therapy with Na(131)I.

Preparation of a Recombinant Adeno-Associated Virus Vector Encoding the Human NIS Gene and Its Expression in Thyroid Cancer Cell Lines

Combining Transfer of Ttf-1 and Pax-8 Gene: A Potential Strategy to Promote Radioiodine Therapy of Thyroid Carcinoma

Experimental targeted radioiodide therapy following transfection of the sodium iodide symporter gene: Effect on clonogenicity in both two-and three-dimensional models

Transfer of Human Sodium/iodide Symporter Gene Induces Iodide Uptake in Melanoma Cells

Stable Expression of Pcdna3.1-Htshr in CHO Cells

Effect of iodine and TSH on the expressions of sodium/iodide symporter mRNA, thyroid peroxidase mRNA and thyroglobulin mRNA in FRTL cell line

Cotransfected sodium iodide symporter and human tyroperoxidase genes following human telomerase reverse transcriptase promoter for targeted radioiodine therapy of malignant glioma cells.

Study on the Transfer of the Rhnis Gene into Human Bile Duct Carcinoma Cells to Induce125i Uptake